An app to monitor the adverse reactions of vaccines and in the meantime Piedmont and Liguria enter into an agreement for vaccination during the holidays. As for the app, a major monitoring project on the safety of anti-Covid vaccines is about to start in Italy, funded byEuropean Medicines Agency (EMA). The project, which will last two years, will allow, through a web app used in 11 European countries, to monitor adverse reactions (therefore safety) in the short and long term, as well as the effectiveness of anti-Covid vaccines. The monitoring will cover patients such as pregnant women, children and adolescents, immunocompromised patients and people with a history of allergy or previous infection with Sars Cov 2.
Meanwhile, the data released by the Ministry of Health continue to instill great confidence and optimism for the near future. According to the ministerial reports, they registered in the last 24 hours new 3.224 positive cases (2.490 yesterday). The new deaths are 166 (yesterday 110). The discharged healed today are 11.348 (yesterday 7.032); altogether the positive cases are 268.145, 8.294 cheaper than yesterday. The molecular and antigenic swabs carried out in the last 24 hours are 252.646 (yesterday 107.481). In the intensive care units they are hospitalized 1.323 Covid patients (yesterday 1.382) while in home isolation they still remain 258.265 people infected with the virus (266.107 yesterday)
Covid vaccines, an app to monitor adverse reactions
App to monitor vaccine reactions. The Dutch Utrecht University Medical Center will lead the project, with our country playing a leading role. In fact, a special Italian network has been set up coordinated by the University of Verona, with the involvement of various vaccination centers, academic centers and regional pharmacovigilance centers. The initiative sees the involvement of Sif, the Italian Society of General Medicine and the National Association of Rheumatic Patients.
Vaccinated people who join the study will have to register on the web app within 48 hours of the vaccine and complete a basic electronic questionnaire. This will be followed by the timed sending of questionnaires by e-mail at 1 and 3 weeks from the first dose and from the second dose. And then 3 and 6 months after the first dose. The aim is to control the long-term effects and the possible occurrence of SARS-COV-2 infection.
Vaccines on vacation, agreement between Piedmont and Liguria
Piemonte and Liguria have signed an agreement to facilitate the vaccination of vacationers on the Ligurian coast or in the Piedmont mountains, during the summer season. It is a real protocol of intent for the “vaccination reciprocity in the tourism sector” signed in Turin by the governors Alberto Cirio and Giovanni Toti. The protocol establishes that residents in Piedmont will be able to receive the anti-Covid vaccination in the vaccination points of Liguria. Just as the residents of Liguria will be able to receive the same vaccination in the vaccination points in Piedmont. This, provided that the stay is for tourist purposes during the summer period and for a duration that makes it difficult to administer the vaccine in the territory of residence.
Furthermore, in the request the interested party must certify the existence of the conditions for the applicability of the agreement. And, again, he must specify his condition as an unvaccinated subject. Or present the certification of the date and type of the first dose received, issue the authorization to process the data. The procedures for booking and registering vaccination and the interoperability of the information systems of Liguria and Piedmont must guarantee the organization of citizens' vaccination operations. Thus allowing those outside the region to access the systems. The vaccination will be notified to the National Covid Vaccination Registry (AVC), which will send the relevant information to the Region of residence.
